<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Trop Med Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Trop Med Infect Dis</journal-id><journal-id journal-id-type="pmc-domain-id">3447</journal-id><journal-id journal-id-type="pmc-domain">tropicalmed</journal-id><journal-id journal-id-type="publisher-id">tropicalmed</journal-id><journal-title-group><journal-title>Tropical Medicine and Infectious Disease</journal-title></journal-title-group><issn pub-type="epub">2414-6366</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12474044</article-id><article-id pub-id-type="pmcid-ver">PMC12474044.1</article-id><article-id pub-id-type="pmcaid">12474044</article-id><article-id pub-id-type="pmcaiid">12474044</article-id><article-id pub-id-type="pmid">41003579</article-id><article-id pub-id-type="doi">10.3390/tropicalmed10090270</article-id><article-id pub-id-type="publisher-id">tropicalmed-10-00270</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Improved Utilisation and Quality of Blood Culture Services Following Operational Research in a Tertiary Hospital in Ghana</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0001-0746-3134</contrib-id><name name-style="western"><surname>Sewornu</surname><given-names initials="R">Rita</given-names></name><xref rid="af1-tropicalmed-10-00270" ref-type="aff">1</xref><xref rid="c1-tropicalmed-10-00270" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9605-6791</contrib-id><name name-style="western"><surname>Boakye-Yiadom</surname><given-names initials="E">Emily</given-names></name><xref rid="af1-tropicalmed-10-00270" ref-type="aff">1</xref><xref rid="af2-tropicalmed-10-00270" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8460-0868</contrib-id><name name-style="western"><surname>Ativi</surname><given-names initials="E">Emmanuel</given-names></name><xref rid="af1-tropicalmed-10-00270" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kwadzokpui</surname><given-names initials="PK">Precious Kwablah</given-names></name><xref rid="af1-tropicalmed-10-00270" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Senahey</surname><given-names initials="B">Bismark</given-names></name><xref rid="af1-tropicalmed-10-00270" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0226-5056</contrib-id><name name-style="western"><surname>Owusu</surname><given-names initials="H">Helena</given-names></name><xref rid="af3-tropicalmed-10-00270" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5257-5074</contrib-id><name name-style="western"><surname>Thekkur</surname><given-names initials="P">Pruthu</given-names></name><xref rid="af4-tropicalmed-10-00270" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1011-8531</contrib-id><name name-style="western"><surname>Kumar</surname><given-names initials="AMV">Ajay M. V.</given-names></name><xref rid="af4-tropicalmed-10-00270" ref-type="aff">4</xref><xref rid="af5-tropicalmed-10-00270" ref-type="aff">5</xref><xref rid="af6-tropicalmed-10-00270" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4369-8245</contrib-id><name name-style="western"><surname>Dodoo</surname><given-names initials="CC">Cornelius C.</given-names></name><xref rid="af7-tropicalmed-10-00270" ref-type="aff">7</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Raymond</surname><given-names initials="J">Josette</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-tropicalmed-10-00270"><label>1</label>Laboratory Department, Ho Teaching Hospital, Ho P.O. Box MA 374, Ghana; <email>ebyiadom@uhas.edu.gh</email> (E.B.-Y.); <email>ativiemmanuel@gmail.com</email> (E.A.); <email>kwadzokpuiprecious@gmail.com</email> (P.K.K.); <email>bismarkelly@gmail.com</email> (B.S.)</aff><aff id="af2-tropicalmed-10-00270"><label>2</label>Department of Microbiology and Immunology, School of Medicine, University of Health and Allied Sciences, Ho P.O. Box PMB 31, Ghana</aff><aff id="af3-tropicalmed-10-00270"><label>3</label>Pharmacy Department, Family Health, Korle-Bu Teaching Hospital, Accra P.O. Box KB 77, Ghana; <email>h.owusu@kbth.gov.gh</email></aff><aff id="af4-tropicalmed-10-00270"><label>4</label>Centre for Operational Research, International Union Against Tuberculosis and Lung Disease (The Union), 2 Rue Jean Lantier, 75001 Paris, France; <email>pruthu.tk@theunion.org</email> (P.T.); <email>akumar@theunion.org</email> (A.M.V.K.)</aff><aff id="af5-tropicalmed-10-00270"><label>5</label>Centre for Operational Research, The Union South-East Asia Office, C6, Qutub Institutional Area, New Delhi 110016, India</aff><aff id="af6-tropicalmed-10-00270"><label>6</label>Department of Community Medicine, Yenepoya Medical College, Yenepoya (Deemed to be University), Mangalore 575018, India</aff><aff id="af7-tropicalmed-10-00270"><label>7</label>Department of Pharmaceutical Microbiology, School of Pharmacy, University of Health and Allied Sciences, Ho P.O. Box PMB 31, Ghana; <email>cdodoo@uhas.edu.gh</email></aff><author-notes><corresp id="c1-tropicalmed-10-00270"><label>*</label>Correspondence: <email>ritayaasewornu@gmail.com</email>; Tel.: +233-243082513 or +233-503770471</corresp></author-notes><pub-date pub-type="epub"><day>18</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>10</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">497678</issue-id><elocation-id>270</elocation-id><history><date date-type="received"><day>29</day><month>7</month><year>2025</year></date><date date-type="rev-recd"><day>09</day><month>9</month><year>2025</year></date><date date-type="accepted"><day>14</day><month>9</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>18</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>28</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-28 11:25:35.080"><day>28</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="tropicalmed-10-00270.pdf"/><abstract><p>Operational research (OR) published in 2023 revealed low utilisation and suboptimal quality of blood culture services at a tertiary hospital in Ghana. To address these, several interventions were implemented, including sensitisation of physicians, training of laboratory staff, use of automated incubation systems, and improved availability of laboratory consumables. To assess the impact of these interventions, we conducted a follow-up study in a cross-section of inpatients (n = 1080) with suspected bloodstream infections (BSI) admitted in 2024. There were three key changes. First, there was a five-fold increase in requests for blood culture from 8% pre-OR to 40% post-OR. Culture requests were more frequent from child health department (63%) and intensive care units (53%) compared to surgery department (15%). Second, there was a reduction in delays: time from hospital admission to culture request was reduced from 2 days to 1 day, and the laboratory turn-around time was reduced from 7 days to 5 days. Third, there was a marginal improvement (<italic toggle="yes">p</italic> = 0.692) in the quality of blood cultures: diagnostic yield improved from 7% to 10%, and the contamination rate was reduced from 16% to 14%. Achieving universal culture utilisation among eligible patients and lowering contamination rates will require a detailed gap analysis and targeted interventions.</p></abstract><kwd-group><kwd>blood culture</kwd><kwd>operational research</kwd><kwd>SORT IT</kwd><kwd>bloodstream infections</kwd><kwd>neonatal sepsis</kwd><kwd>laboratory quality</kwd><kwd>antimicrobial resistance</kwd><kwd>antimicrobial susceptibility testing</kwd><kwd>Volta Region</kwd><kwd>Ghana</kwd></kwd-group><funding-group><award-group><funding-source>TDR</funding-source><award-id>TDR.HQTDR 2422924-4.1-72863</award-id></award-group><funding-statement>This SORT IT programme was funded by TDR (Grant Number: TDR.HQTDR 2422924-4.1-72863). The APC was also funded by TDR. TDR is able to conduct its work thanks to the commitment and support of a variety of funders. A full list of TDR donors is available at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://tdr.who.int/about-us/our-donors">https://tdr.who.int/about-us/our-donors</uri> (accessed on 23 July 2024).</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-tropicalmed-10-00270"><title>1. Introduction</title><p>Bloodstream infections (BSI) are serious infections associated with high morbidity, permanent disability, and mortality, requiring hospital admission and emergency care [<xref rid="B1-tropicalmed-10-00270" ref-type="bibr">1</xref>,<xref rid="B2-tropicalmed-10-00270" ref-type="bibr">2</xref>]. The management of BSI is complicated by the increasing trend in antimicrobial resistance (AMR) among the pathogens causing them. An estimated 47&#8211;50 million cases and 11 million deaths from BSI occur annually worldwide, and two-fifths of these occur in children under 5 years [<xref rid="B1-tropicalmed-10-00270" ref-type="bibr">1</xref>].</p><p>The burden of AMR in hospitalised patients with BSI is globally high, with the greatest impact in Africa [<xref rid="B3-tropicalmed-10-00270" ref-type="bibr">3</xref>,<xref rid="B4-tropicalmed-10-00270" ref-type="bibr">4</xref>]. This is critically evident in Ghana, where a recent systematic review confirmed a high prevalence of resistance observed among various bacterial species with key pathogens like <italic toggle="yes">Acinetobacter</italic> spp., exhibiting resistance to ceftriaxone of &gt;80%. Furthermore, studies specific to BSI in Ghana have shown a rise in the prevalence of multi-drug resistant (MDR) bacteria [<xref rid="B5-tropicalmed-10-00270" ref-type="bibr">5</xref>,<xref rid="B6-tropicalmed-10-00270" ref-type="bibr">6</xref>,<xref rid="B7-tropicalmed-10-00270" ref-type="bibr">7</xref>]. The global action plan on AMR recognises the inappropriate use of antimicrobials in BSI as one of the drivers of AMR [<xref rid="B8-tropicalmed-10-00270" ref-type="bibr">8</xref>]. Therefore, identifying the causative organism in BSI and understanding its resistance patterns are essential for adapting antimicrobial therapy [<xref rid="B9-tropicalmed-10-00270" ref-type="bibr">9</xref>]. Additionally, blood culture and drug susceptibility testing (CDST) provide essential data for developing local antibiograms, which are critical for guiding effective empirical therapy and for surveillance of regional bacterial resistance trends [<xref rid="B10-tropicalmed-10-00270" ref-type="bibr">10</xref>]. It is also a critical component of the facility-level antimicrobial stewardship programme. This is especially important in resource-constrained settings like sub-Saharan Africa, where the high prevalence of BSI is often accompanied by weak diagnostics for clinical management [<xref rid="B11-tropicalmed-10-00270" ref-type="bibr">11</xref>]. Even though laboratory diagnostics for BSI are shifting towards using rapid diagnostic tests, including molecular tests, traditional blood cultures, and CDST remain an integral part of the diagnostic bouquet and provide opportunities for diagnostic stewardship [<xref rid="B12-tropicalmed-10-00270" ref-type="bibr">12</xref>].</p><p>For effective management of BSI, blood samples for cultures must be drawn prior to the initiation of empirical therapy, which can then be modified based on the CDST results [<xref rid="B13-tropicalmed-10-00270" ref-type="bibr">13</xref>]. However, compliance with these established protocols for the diagnosis and treatment of BSI is not strictly adhered to. Errors in suspecting BSI often lead to a delay in initiating the request for blood culture, which, in turn, can lead to a delay in diagnosis and initiation of effective treatment. The utilisation of blood culture services varies across countries and health facilities, even in resource-rich countries [<xref rid="B14-tropicalmed-10-00270" ref-type="bibr">14</xref>]. Also, the turnaround time (TAT) for blood cultures in laboratories needs to be fast enough to have a favourable effect on management [<xref rid="B15-tropicalmed-10-00270" ref-type="bibr">15</xref>]. Furthermore, high contamination rates and prolonged TAT not only delay effective treatment and worsen outcomes but also frequently lead to the unnecessary use of broad-spectrum antimicrobials, driving antimicrobial resistance and imposing significant additional costs on both patients and the healthcare system [<xref rid="B7-tropicalmed-10-00270" ref-type="bibr">7</xref>].</p><p>The Ho Teaching Hospital (HTH) is a tertiary health facility in Ghana that receives referrals from primary and secondary health facilities for the management of specialised and complicated cases. An operational research (OR) study at the HTH published by Boakye-Yiadom et al. in August 2023 revealed four key findings: (i) a low proportion of patients with suspected BSI had blood cultures requested (8%); (ii) a delay in requesting blood culture (median of 2 days from admission); (iii) high contamination rates in blood cultures (16%); and (iv) long laboratory turnaround times (median of seven days) [<xref rid="B16-tropicalmed-10-00270" ref-type="bibr">16</xref>]. The antimicrobial resistance patterns were not reported in this study due to inadequate numbers of bacteria isolated. Non-compliance with Clinical and Laboratory Standards Institute (CLSI) guidelines was observed in the selection of antimicrobials for testing. This included testing the wrong antimicrobials and omitting recommended ones [<xref rid="B16-tropicalmed-10-00270" ref-type="bibr">16</xref>]. Hospital exit outcomes were also not reported due to challenges in retrieving the data from the electronic health records (EHR).</p><p>Following this study, some interventions were implemented to improve the utilisation and quality of blood culture services for diagnosing BSI. These included (i) sensitisation and training of the treating physicians and nurses such that they develop a high index of suspicion for BSI and use the correct techniques for collecting blood samples; and (ii) the use of automated incubation systems and improving the availability of laboratory consumables for blood CDST. In addition, the laboratory information management system and the EHR were strengthened to better capture key variables such as antimicrobial resistance data and hospital exit outcomes.</p><p>To assess the impact of these interventions, we conducted a follow-up operational research study to assess if there has been any change in the utilisation and quality of blood culture services among inpatients with suspected BSI at the HTH in 2024. Our specific objectives were (i) to assess the number (proportion) who had a blood culture requested and performed (an indicator of utilisation); (ii) to assess the number (proportion) of specimens that were culture-positive, culture-negative, and culture-contaminated (an indicator of quality); (iii) to describe the common pathogens identified and their antimicrobial resistance patterns; (iv) to assess median duration between (a) the date of hospital admission and the date of specimen receipt at the laboratory and (b) the date of specimen receipt and the date of reporting of results (turnaround time); and (v) to describe the hospital exit outcomes and associated factors.</p></sec><sec id="sec2-tropicalmed-10-00270"><title>2. Materials and Methods</title><sec id="sec2dot1-tropicalmed-10-00270"><title>2.1. Study Design</title><p>This was a cross-sectional study with a retrospective uncontrolled before-and-after approach using secondary data from routine laboratory records and patient EHR between January and December 2024.</p></sec><sec id="sec2dot2-tropicalmed-10-00270"><title>2.2. General Setting</title><p>Ghana is a tropical country situated on the west coast of Africa and has a population of 33 million [<xref rid="B17-tropicalmed-10-00270" ref-type="bibr">17</xref>]. The average life expectancy at birth is 64 years, and the World Bank has classified Ghana as a lower-middle-income country [<xref rid="B17-tropicalmed-10-00270" ref-type="bibr">17</xref>].</p></sec><sec id="sec2dot3-tropicalmed-10-00270"><title>2.3. Specific Setting</title><p>The HTH, affiliated with the University of Health and Allied Sciences (UHAS), is a 306-bed capacity health facility offering tertiary healthcare services to the inhabitants of the Volta and Oti regions of Ghana and neighbouring Togo. The medical directorate comprises departments of internal medicine, surgery, obstetrics and gynaecology, child health, public health, and diagnostics and rehabilitation, an accident and emergency unit, and both adult and neonatal intensive care units. In 2024, the outpatient attendance was 212,129, and admissions were 10,936 (Source: Annual Performance Review Report, HTH, Ghana, 2024).</p><p>Laboratory services are centralised and span haematology, biochemistry, histopathology, serology, microbiology, and blood banking. Additionally, the laboratory serves as the public health reference laboratory for tuberculosis and HIV diagnosis and is part of the network of laboratories for COVID-19 testing services in the country. It is also a sentinel site for AMR surveillance in the country.</p><p>Health information, including patient, laboratory, and pharmacy records, is managed electronically&#8212;mostly with the Lightwave Health Information Management System software (LHIMS), which feeds into the District Health Information Management System (DHIMS2) of the Ghana Health Service.</p><p>While approximately 90% of the patients are covered by the National Health Insurance Scheme (NHIS), it does not fully cover the costs of all the diagnostic tests, including blood CDST services.</p><sec id="sec2dot3dot1-tropicalmed-10-00270"><title>2.3.1. Blood Culture Processing Workflow in HTH</title><p>Blood culture requests are made by the attending physician via the patient&#8217;s EHR for clinically indicated cases. Physicians or nurses obtain aerobic blood culture bottles from the bacteriology unit for inpatients; anaerobic cultures were not part of the standard protocol for this study. Blood samples were drawn from peripheral veins, usually on the forearm for both adults and children. In accordance with the site&#8217;s protocol at the time of the study, skin antisepsis was performed using a 70% ethanol solution, allowing it to dry completely. Blood was directly drawn into a syringe&#8212;1&#8211;3 mL for neonates and 8&#8211;10 mL for adults, which are volumes deemed appropriate per standard guidelines&#8212;and aseptically transferred into the aerobic culture bottle. Upon receipt in the bacteriology laboratory, all samples underwent a visual inspection to verify the adequacy of the sample volume, in addition to checking labelling completeness. Specimens were then logged into blood culture reception registers (electronic and paper-based) and assigned a unique laboratory accession number.</p></sec><sec id="sec2dot3dot2-tropicalmed-10-00270"><title>2.3.2. Laboratory Processing of Blood Cultures</title><p>Samples received at the blood culture bench are once again checked to confirm that the information on the request form, sample label, and specimen receipt register match. The culture bottle is then scanned, placed into an automated incubator (BD Bactec&#8482;, Becton, Dickinson and Company, Dun Laoghaire, Ireland), and incubated aerobically at 35&#8211;37 &#176;C. The incubator scans the bottles every 10 min to detect any bacterial growth. Any bottle in which growth is detected is flagged red with a corresponding alarm. After five days of incubation in the automated incubator, if there is no growth, the equipment flags green, and the culture bottle is taken out and recorded as no bacterial growth (negative). This five-day protocol is consistent with the manufacturer&#8217;s guidelines for the detection of common bacterial and fungal pathogens and aligns with the objectives of this study. The laboratory scientist on duty then brings that bottle out, disinfects the cover with 70% ethanol, and using a sterile needle draws out 0.5 mL of the fluid. This is Gram stained and sub-cultured on appropriate media (one each on blood agar, chocolate agar in a candle-extinction jar, and MacConkey agar) and incubated aerobically at 35&#8211;37 &#176;C. Upon growth of a bacterial pathogen, these are subsequently processed by biochemical means for phenotypic identification. Even though it is recommended to test paired samples, most of the blood samples received at the laboratory are solitary samples.</p><p>Gram-positive pathogens recovered generally include <italic toggle="yes">Staphylococcus aureus</italic> and <italic toggle="yes">Streptococcus</italic> spp. Gram-negative pathogens recovered include <italic toggle="yes">Escherichia coli</italic>, <italic toggle="yes">Klebsiella</italic> spp., <italic toggle="yes">Pseudomonas aeruginosa</italic>, and <italic toggle="yes">Acinetobacter</italic> spp. Fungal pathogens are occasionally isolated and are often either <italic toggle="yes">Candida</italic> spp. or <italic toggle="yes">Aspergillus</italic> spp. Likely contaminants recovered generally include Coagulase-negative <italic toggle="yes">Staphylococcus</italic>, <italic toggle="yes">Corynebacterium</italic> spp., and <italic toggle="yes">Bacillus</italic> spp. The classification of an isolate as a potential contaminant was based on a combination of its identity as common skin flora (Coagulase-negative staphylococci [CoNS], <italic toggle="yes">Corynebacterium species</italic>, <italic toggle="yes">Bacillus species</italic>, <italic toggle="yes">Micrococcus species</italic>, or <italic toggle="yes">Propionibacterium</italic>) and a lack of clinical evidence of infection supporting its role as a pathogen; for example, the attending physician did not initiate targeted antimicrobial therapy.</p><p>Antimicrobial susceptibility testing is performed via disc diffusion as per CLSI guidelines [<xref rid="B18-tropicalmed-10-00270" ref-type="bibr">18</xref>]. Gram-positive organisms are tested against penicillin, cefoxitin, erythromycin, tetracycline, ciprofloxacin, gentamicin, clindamycin, azithromycin, and co-trimoxazole. Gram-negative bacteria are tested against ceftazidime, ceftriaxone, cefepime, meropenem, tobramycin, piperacillin-tazobactam, amikacin, and ciprofloxacin. The zone of inhibition in both cases is read using the INGCO Digital Caliper (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.ingoco.com">www.ingoco.com</uri>, China). The quality control of antibiotic discs and testing procedures was ensured through routine use of reference strains <italic toggle="yes">Escherichia coli</italic> ATCC 25922 and <italic toggle="yes">Staphylococcus aureus</italic> ATCC 29213.</p></sec></sec><sec id="sec2dot4-tropicalmed-10-00270"><title>2.4. Study Population</title><p>We included all inpatients at the HTH from 1st January to 31st December 2024 with clinical diagnoses of suspected BSI, including sepsis, septicaemia, septic shock, pneumonia, neonatal sepsis, catheter-related BSI, puerperal sepsis, septic abortion, urosepsis, endocarditis, meningitis, intra-cerebral abscess, pyelonephritis, enteric or typhoid fever, septic arthritis, peritonitis, cholecystitis, cholangitis, biliary tract infection, typhoid/enteric fever, intra-abdominal abscess, pelvic abscess, fever/pyrexia of unknown origin, osteomyelitis, Ludwig&#8217;s angina, and Fournier&#8217;s gangrene.</p></sec><sec id="sec2dot5-tropicalmed-10-00270"><title>2.5. Data Variables and Data Collection Process</title><p>In LHIMS, we searched and extracted data for all inpatients admitted during the study period. Additionally, we extracted data for all inpatients for whom blood cultures were requested and processed during the study period. We then merged the laboratory records for patients for whom blood cultures were performed using the patient hospital ID number.</p><p>Variables extracted were the hospital ID, age, gender, dates of admission and discharge, ward of admission, clinical diagnosis, whether CDST was requested (yes/no), and hospital exit outcomes. Variables for laboratory data extracted included the date of specimen receipt by the laboratory, the result of blood culture (positive, negative, contaminated), whether a final report was issued (yes/no), and the date of the final report issue. For those with positive cultures, information on bacterial isolates identified and antimicrobial susceptibility results were extracted. These entries were subsequently anonymised, assigned unique study identification numbers, and exported for analysis.</p></sec><sec id="sec2dot6-tropicalmed-10-00270"><title>2.6. Data Analysis</title><p>Data were extracted from the LHIMS in Microsoft Excel format (Microsoft corporation&#8482;) and exported to Stata (version 16.0, Copyright 1985&#8211;2019, StataCorp LLC, College Station, TX, USA) for analysis. We summarised the baseline demographic and clinical data of patients using frequency and proportions for categorical variables. For the continuous variables, we used mean and standard deviation or median and interquartile range, as appropriate.</p><p>The entire cascade of care was depicted in the form of a flowchart and included the following outcome indicators: (i) proportion of patients with suspected BSI for whom cultures were requested (indicator of utilisation); (ii) proportion of specimens processed at the laboratory and among them, the culture-positive proportion, the culture-negative proportion, and the contaminated proportion (indicator of quality); and (iii) frequencies and proportions of bacteria identified. Median (IQR) durations between (a) hospital admission and culture specimen receipt and (b) culture specimen receipt and the sharing of results were calculated. Hospital exit outcomes were categorised as favourable (recovered or discharged) or unfavourable (died, lost to follow-up, referred for further care, absconded, discharged against medical advice).</p><p>To assess associations of demographic and clinical variables with the outcome indicators, we used chi-square test for comparing proportions. Multivariable analysis using modified Poisson regression with a robust variance estimator was conducted to assess the independent association of demographic and clinical characteristics of patients with (i) request for blood CDST and (ii) unfavourable hospital exit outcomes. Collinearity between the variables was assessed using variance inflation factor (VIF). Variables with a VIF of &gt;10 were excluded from the multivariable analysis. Prevalence ratios (PR) or risk ratios (RR), as appropriate, with a 95% confidence interval (CI), were calculated as measures of association. A <italic toggle="yes">p</italic>-value &lt; 0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="sec3-tropicalmed-10-00270"><title>3. Results</title><sec id="sec3dot1-tropicalmed-10-00270"><title>3.1. Demographic, Clinical Characteristics, and Factors Associated with Blood Culture Request</title><p>The demographic and clinical characteristics of the study population are shown in <xref rid="tropicalmed-10-00270-t001" ref-type="table">Table 1</xref>. There were a total of 1080 inpatients with suspected BSI during the study period. Of them, 524 (49%) were males and 249 (23%) were neonates. Nearly 40% of the patients were from the department of child health followed by internal medicine (24%) and accident and emergency departments (16%).</p></sec><sec id="sec3dot2-tropicalmed-10-00270"><title>3.2. Utilisation and Quality of Blood Cultures</title><p><xref rid="tropicalmed-10-00270-f001" ref-type="fig">Figure 1</xref> depicts the indicators related to the utilisation and quality of blood cultures. Of the 1080 inpatients with clinically suspected BSI, a culture was requested by the clinicians for 432 (40%). Blood samples of all 432 patients were received by the laboratory and of them, culture results were issued for 420 (97%). Of the latter, true pathogens were isolated in 10%, likely contaminants were observed in 14%, and no growth was seen in 76% of the samples.</p><p>The blood culture processing times are shown in <xref rid="tropicalmed-10-00270-t002" ref-type="table">Table 2</xref>. The median (IQR) duration between admission and sample receipt at the laboratory was 1 (0&#8211;2) day. The median (IQR) laboratory turnaround time (time between receipt of sample at the laboratory and issuance of results) was 5 (5&#8211;6) days.</p></sec><sec id="sec3dot3-tropicalmed-10-00270"><title>3.3. Organisms Isolated and Their Resistance Patterns</title><p>Of the organisms isolated, 12/42 (28%) were Gram-positive bacteria (<italic toggle="yes">Staphylococcus aureus</italic>, <italic toggle="yes">Streptococcus pyogenes</italic>), 27/42 (64%) were Gram-negative bacteria (<italic toggle="yes">Pseudomonas</italic> spp., <italic toggle="yes">Acinetobacter</italic> spp., <italic toggle="yes">Achromobacter</italic> spp., and Enterobacterales, which include <italic toggle="yes">Klebsiella</italic> spp., <italic toggle="yes">Proteus mirabilis</italic>, <italic toggle="yes">Escherichia coli</italic>, <italic toggle="yes">Citrobacter</italic> spp., <italic toggle="yes">Enterobacter</italic> spp., and <italic toggle="yes">Providencia</italic> spp.), and 3/42 (8%) were yeast-like cells. The likely contaminants were coagulase-negative <italic toggle="yes">Staphylococcus</italic> 54/59 (91.5%), <italic toggle="yes">Bacillus</italic> spp. 3/59 (5.1%), and <italic toggle="yes">Micrococcus</italic> spp. 2/59 (3.4%). Critical World Health Organization (WHO) Priority bacterial pathogens identified during the study period included third-generation cephalosporin-resistant Enterobacterales and carbapenem-resistant Enterobacterales. In addition, some isolates of methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic> (MRSA), classified as a high-priority pathogen by the WHO, were also detected. <xref rid="tropicalmed-10-00270-t003" ref-type="table">Table 3</xref> provides a summary of the WHO priority bacterial pathogens tested and identified.</p></sec><sec id="sec3dot4-tropicalmed-10-00270"><title>3.4. Factors Associated with Blood Culture Request</title><p><xref rid="tropicalmed-10-00270-t001" ref-type="table">Table 1</xref> depicts the factors associated with blood culture request. The likelihood of CDST being requested was significantly higher in children aged 0&#8211;11 years (62&#8211;69%), with PRs ranging from 2.5 to 2.8, indicating more than double the likelihood of CDST requests compared to patients aged 12&#8211;64 years (21&#8211;30%). Compared to pneumonia (25.3%), CDST was more likely to be requested in neonatal sepsis (60.7%), other sepsis (52.4%), and other conditions (30.0%). Patients admitted to the child health department (62.6%), intensive care units (53.3%), internal medicine (31.0%), and accident and emergency (24.4%) had significantly higher uptake of CDST compared to the surgery department (15.1%).</p></sec><sec id="sec3dot5-tropicalmed-10-00270"><title>3.5. Factors Associated with Hospital Exit Outcomes</title><p>Among the 1080 inpatients with BSI, 22.5% experienced unfavourable outcomes (21.3% death, 0.6% referral for further care, 0.6% absconded). Factors associated with unfavourable outcomes are shown in <xref rid="tropicalmed-10-00270-t004" ref-type="table">Table 4</xref>. The risk of unfavourable outcomes was higher in patients aged 45 years and above compared to neonates. Patients admitted in intensive care units, accident and emergency, and internal medicine departments had significantly higher risk of unfavourable outcomes compared to those in the department of child health. Additionally, patients with &#8220;no bacterial growth&#8221; or &#8220;contaminated cultures&#8221; had significantly worse outcomes than those with confirmed bacterial infections.</p></sec></sec><sec sec-type="discussion" id="sec4-tropicalmed-10-00270"><title>4. Discussion</title><p>This is the first study from Ghana examining the impact of a package of interventions post-OR study on the utilisation and quality of blood culture services at a tertiary care hospital [<xref rid="B16-tropicalmed-10-00270" ref-type="bibr">16</xref>]. There were three key changes. First, there was a five-fold increase in request for blood culture from 8% pre-OR to 40% post-OR [<xref rid="B16-tropicalmed-10-00270" ref-type="bibr">16</xref>]. Second, there was a reduction in delays involved in the process: time from hospital admission to culture request was reduced from 2 days to 1 day, and the laboratory turn-around time was reduced from 7 days to 5 days. Third, while we observed a numerical increase in diagnostic yield (7% to 10%) and a decrease in contamination (16% to 14%), both metrics remain suboptimal (<italic toggle="yes">p</italic> &gt; 0.05) and have direct, negative implications for patient care and antimicrobial stewardship. A contamination rate of 14% far exceeds the recommended target of &lt;3% [<xref rid="B19-tropicalmed-10-00270" ref-type="bibr">19</xref>,<xref rid="B20-tropicalmed-10-00270" ref-type="bibr">20</xref>]. This high rate likely leads to the misinterpretation of contamination as bacteraemia, prompting the unnecessary use of broad-spectrum antibiotics (e.g., vancomycin) for common skin flora. This practice directly drives antimicrobial resistance, increases treatment costs, and exposes patients to potential drug-related adverse effects.</p><p>Furthermore, the persistently low diagnostic yield of 10% suggests that blood cultures are often requested for patients with a low pre-test probability of bacteremia, or that prior antibiotic use is common. This represents inefficient use of limited laboratory resources in a resource-constrained setting. Both high contamination and low yield undermine the core goals of Ghana&#8217;s National Action Plan on AMR by hindering the collection of reliable surveillance data and promoting inappropriate antimicrobial use, rather than enabling targeted, effective therapy.</p><p>Nonetheless, the observed changes were likely to be due to a package of targeted interventions implemented after the initial operational research study. These included (i) the full-scale operation of an automated blood culture incubator; (ii) addressing the procurement and supply chain gaps for culture bottles and laboratory reagents; (iii) sensitisation of the core hospital management and clinicians at various diagnostic departments, as well as a dedicated Antimicrobial Stewardship (AMS) programme under the Commonwealth Partnership Antimicrobial Stewardship (CwPAMS) programme, which raised awareness about the need to request for cultures to aid targeted treatment; and (iv) capacity-building support for the laboratory staff [<xref rid="B21-tropicalmed-10-00270" ref-type="bibr">21</xref>,<xref rid="B22-tropicalmed-10-00270" ref-type="bibr">22</xref>,<xref rid="B23-tropicalmed-10-00270" ref-type="bibr">23</xref>].</p><p>Under-use of blood cultures in LMICs is well-documented and largely due to limited laboratory capacity [<xref rid="B24-tropicalmed-10-00270" ref-type="bibr">24</xref>]. Our baseline data of 8% uptake is consistent with other Ghanaian reports of poor blood culture utilisation [<xref rid="B13-tropicalmed-10-00270" ref-type="bibr">13</xref>]. The post-intervention increase to 40% represents a major step towards meeting the Ghana National Standard Treatment Guidelines&#8217; recommendation that all suspected BSIs should have cultures [<xref rid="B25-tropicalmed-10-00270" ref-type="bibr">25</xref>].</p><p>The uptake of cultures was significantly higher among neonates and those who were severely ill (patients admitted to intensive care units and accident and emergency departments) compared to inpatients from surgery and obstetrics and gynaecology departments. The reasons for this are unclear and need further investigation. While pre-intervention barriers such as lower clinical suspicion of BSI and hesitancy to request testing may have historically contributed to this disparity, the institution of sustained sensitisation and stewardship interventions was specifically designed to mitigate these factors by raising awareness and demonstrating utility. Therefore, the persistence of this gap post-intervention suggests that intrinsic differences in the patient case mix, where surgical and obstetrics/gynaecology patients may less frequently present with classic sepsis syndromes compared to critically ill or neonatal patients, is now a more likely explanatory factor than physician resistance. This warrants further investigation to tailor future diagnostic stewardship efforts for these specific departments. The high uptake at the child health department is similar to observations made by Rahden et al. in Gambia [<xref rid="B26-tropicalmed-10-00270" ref-type="bibr">26</xref>].</p><p>The overall decrease in laboratory turnaround time may be attributable to the use of automated blood culture system in the bacteriology laboratory and overall workflow improvements. Automated blood culture systems with automated alerts and continuous bottle monitoring are well known to speed up detection. Many recent studies in LMICs show that automated incubators detect &gt;80% of positive bottles within 24 h compared to approximately 65&#8211;94% in the manual system [<xref rid="B24-tropicalmed-10-00270" ref-type="bibr">24</xref>]. Likewise, five days of incubation is generally sufficient in automated systems, whereas older manual protocols involved incubation for 7 days without added yield. The reduced turnaround time has important clinical implications. Faster results allow for the earlier initiation of targeted treatment and antibiotic de-escalation, where necessary [<xref rid="B27-tropicalmed-10-00270" ref-type="bibr">27</xref>]. The CDC guidelines note that obtaining blood cultures prior to antibiotics is key to enabling the later de-escalation of broad-spectrum therapy [<xref rid="B20-tropicalmed-10-00270" ref-type="bibr">20</xref>]. In a low-resource hospital such as the HTH, shaving two days off results means that clinicians can adjust treatment more quickly for better management of patients.</p><p>Despite these gains, blood culture contamination remained high at 14%, only marginally down from 16% pre-OR. This far exceeds international benchmarks such as that of the CLSI and related guidelines, which set a contamination target of &lt;3%, with an ideal closer to 1% [<xref rid="B20-tropicalmed-10-00270" ref-type="bibr">20</xref>]. High contamination has several adverse effects [<xref rid="B28-tropicalmed-10-00270" ref-type="bibr">28</xref>]. It drives false-positive results with skin commensals, wastes laboratory and clinical resources, and can mislead therapy [<xref rid="B28-tropicalmed-10-00270" ref-type="bibr">28</xref>]. CDC guidance stresses that even basic steps, such as adequate skin antisepsis with 70% ethanol and allowing for time to dry, disinfecting the bottle cap, and using a good phlebotomy technique, are essential to reduce contamination rates [<xref rid="B20-tropicalmed-10-00270" ref-type="bibr">20</xref>]. The persistently elevated rate shows that further training and quality monitoring are needed. For instance, routine surveillance of contamination rates by ward, as recommended in infection control programmes, could identify problem areas for further interventions. One of the recommended procedures to differentiate between &#8220;true pathogens&#8221; and &#8220;likely contaminants&#8221; is the use of paired samples. This is not being practiced at the HTH owing to cost constraints and needs urgent review. Our immediate quality improvement plan, therefore, will be to implement a two-step antisepsis protocol, which involves 70% ethanol followed by povidone&#8211;iodine, and to intensify efforts within our antimicrobial stewardship programme to promote the collection of paired blood samples. This is essential to definitively differentiate true pathogens from contaminants. While paired sampling has been historically limited by cost constraints, we propose to urgently review this policy as a vital investment. Furthermore, we will introduce routine ward-specific surveillance of contamination rates to identify and target problem areas for additional interventions.</p><p>The overall blood culture positivity for true pathogens remained low (10%), though showing an increment compared to the previous study (7%). This is in line with other Ghanaian and African reports. A nationwide Ghana surveillance found only 11.2% of cultures grew pathogens, and in a large Ghana referral centre, only 9.3% of blood cultures yielded true pathogens. Low diagnostic yield suggests cultures being requested for patients with a low probability of bacteremia, exposure to antibiotics prior to culture, or limited incubation of blood cultures to a maximum of five days, which may have failed to detect some slow-growing pathogens. Prior studies in Ghana have noted that early empirical antibiotics, often given before culture request, and even misdiagnosis of other febrile illnesses, contributes to low yields. It is also possible that inadequate blood volume reduced sensitivity. Low yield has clinical implications; thus, most patients with negative cultures will be treated empirically. Without a confirmed pathogen, clinicians lack definitive guidance to narrow therapy, underscoring the need to improve diagnostic accuracy. Diagnostic stewardship is therefore vital, and blood CDST requests should be reserved for patients with true clinical sepsis and obtained before antibiotics are started to maximise both yield and the utility of the results [<xref rid="B29-tropicalmed-10-00270" ref-type="bibr">29</xref>]. In practical terms, our findings argue for refining the indications for blood culture, for example, using clinical prediction rule, ensuring adequate draw volume, and reviewing the protocol for duration of blood culture to include a 14-day incubation time for patients with suspected endocarditis.</p><p>The pathogen and CDST data are concerning for emerging resistance. Although numbers were small, most (five out of seven) of the <italic toggle="yes">Staphylococcus aureus</italic> isolates were methicillin-resistant (MRSA). This high prevalence is likely a direct consequence of the selective pressure exerted by the widespread empirical use of broad-spectrum antibiotics. This needs to be considered while recommending the antibiotics used for empirical therapy. Among Gram-negatives, resistance to third-generation cephalosporins was high. This parallels other Ghana findings, such as that reported in a cancer centre where 61% of Enterobacteriaceae were cefotaxime-resistant (mostly ESBLs) [<xref rid="B30-tropicalmed-10-00270" ref-type="bibr">30</xref>], and earlier (2010&#8211;13) data from Korle-Bu Teaching Hospital showed a year-on-year rise in cephalosporin-resistant Enterobacteriaceae among BSIs [<xref rid="B31-tropicalmed-10-00270" ref-type="bibr">31</xref>]. One isolate in our series was even resistant to carbapenems. While rare, carbapenem-resistant bloodstream pathogens have been reported in Ghana and are regarded as critical threats. The WHO&#8217;s 2024 priority pathogens list highlights carbapenem-resistant Gram-negatives and MRSA as top priorities [<xref rid="B32-tropicalmed-10-00270" ref-type="bibr">32</xref>]. These local resistance patterns underscore the danger of relying on outdated empiric regimens. In the absence of real-time culture data, clinicians may be unknowingly prescribing ineffective antibiotics, which may, in turn, be leading to poor outcomes. As shown in our study, patients with a definitive diagnosis had better outcomes compared to those with &#8220;contaminated&#8221; or &#8220;negative&#8221; results.</p><p>The broad antimicrobial resistance observed here, including high MRSA and resistance to third-generation cephalosporins, thus heightens the urgency of stewardship and justifies the emphasis in Ghana&#8217;s National Action Plan that empirical therapy should be guided by up-to-date local antibiograms.</p><p>The overall mortality rate of 21.3% observed in our study aligns with the grave prognosis associated with bloodstream infections (BSI) in similar resource-limited settings across sub-Saharan Africa. A study from a large tertiary hospital in Addis Ababa, Ethiopia, reported a stark fivefold increase in mortality among patients with a positive blood culture (50.0% vs. 9.8% for culture-negative patients) [<xref rid="B33-tropicalmed-10-00270" ref-type="bibr">33</xref>]. This pattern of high mortality is further exacerbated by antimicrobial resistance (AMR); the same Ethiopian study reported a devastating 100% mortality rate among all 11 patients infected with third-generation cephalosporin-resistant Enterobacteriaceae [<xref rid="B33-tropicalmed-10-00270" ref-type="bibr">33</xref>]. While direct causal comparisons cannot be drawn, the consistent theme across these geographically distinct African cohorts is that BSI mortality remains critically high and is profoundly influenced by AMR, which cripples the efficacy of standard empiric therapy. This collective evidence underscores the urgent need for improved diagnostic stewardship and access to effective antibiotics to mitigate this persistent threat to patient survival in our region.</p><p>This study has several strengths. First, we had a large sample and included everyone with suspected BSI during the study period, thus enabling robust analysis of data including factors associated with culture request and hospital exit outcomes. Second, we used routine hospital data which are likely to reflect ground realities. Third, we followed the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines in conducting and reporting the results of our study.</p><p>There are some limitations too. First, the overall numbers of true pathogens were small. Hence, caution is needed when interpreting the magnitude of resistance patterns observed. Second, the number of demographic and clinical factors available to assess associations with culture uptake and outcomes were limited (with some of them being collinear to each other). Third, we did not investigate the reasons for lower uptake from certain departments such as surgery and obstetrics and gynaecology. This needs further investigation using qualitative inquiry. However, the uneven uptake of blood culture across departments, reflecting real-world clinical practice, limits the comparability of AMR patterns and outcomes between these patient groups. The findings on resistance patterns are therefore most representative of the patient populations in high-uptake departments (e.g., Child Health, ICU) and may not be generalizable to all inpatients with suspected BSI. Fourth, using the interval from admission to issuance of laboratory report as a proxy for diagnostic lead time was based on the assumption that all patients had these infections at admission and did not account for possible healthcare-associated infections. Furthermore, the high proportion of solitary blood culture samples received by the laboratory represents a key limitation. The inability to obtain paired samples from separate venipuncture sites impedes our ability to reliably differentiate true bloodstream infection from contamination, particularly for common skin commensals like coagulase-negative staphylococci. This likely affects the precision of our reported contamination rate and the clinical interpretation of some isolates.</p><p>Despite these limitations, our study has many implications and provides the basis for several recommendations. First, we need to investigate the reasons for the gap in the uptake of blood culture and act based on these findings. Moving from 40% to 100% will not be easy and will require a combination of approaches, which include (i) the targeted engagement of departments that are not optimally involved; (ii) a review of the cost structure of CDST services and collaboration with the Ministry of Health to offer it to patients free of charge; and (iii) the augmentation of traditional diagnostics such as CDST with rapid molecular and advanced identification systems such as Vitek&#8212;this is likely to reduce the turnaround times [<xref rid="B34-tropicalmed-10-00270" ref-type="bibr">34</xref>]. Second, there is an urgent need to revisit the clinical criteria of suspected BSI to ensure culture services are offered and prioritised to the needy patients&#8212;this will improve the diagnostic yield. Third, the practice of testing paired blood samples should be promoted. This will help in differentiating contaminants from true pathogens and in the institution of targeted therapy. Finally, information on the resistance patterns of bacteria should be used to periodically update the empirical therapy regimens.</p></sec><sec sec-type="conclusions" id="sec5-tropicalmed-10-00270"><title>5. Conclusions</title><p>In conclusion, we found that a package of interventions based on the findings of an operational research study led to a major improvements in utilisation (five-fold increase in uptake of blood culture) and modest improvements in the quality of blood culture services&#8212;namely, a reduction in laboratory turnaround times and a marginal reduction in contamination rates&#8212;in a tertiary hospital in Ghana. Several recommendations have been made to achieve universal coverage of all patients with bloodstream infections with blood culture services.</p></sec></body><back><ack><title>Acknowledgments</title><p>This publication was developed through the Structured Operational Research and Training Initiative (SORT IT), a global partnership led by TDR, UNICEF, UNDP, the World Bank and, the WHO Special Programme for Research and Training in Tropical Diseases, hosted at the World Health Organization (WHO). The specific SORT IT programme that led to this publication included a collaboration between TDR, The World Health Organization&#8217;s Ghana Country Office, and the following Ghanaian and International Institutions (listed in alphabetic order). International Institutions: The Centre for Operational Research of the International Union Against Tuberculosis and Lung Disease (The Union), Paris and India offices; The Institute of Tropical Medicine, Antwerp, Belgium; Jawaharlal Institute of Postgraduate Medical Education &amp; Research (JIPMER), Pondicherry; The National TB Control Programme of Kyrgyzstan; The Tuberculosis Research and Prevention Center NGO, Armenia; University of St Andrews Medical School, Scotland, UK. Ghana institutions: Ho Teaching Hospital, Ghana; University of Health and Allied Sciences, Ghana; 37 Military Hospital, Ghana; Bishop Ackon Memorial Christian Eye Centre, Ghana; Council for Scientific and Industrial Research&#8212;Animal and Water Research Institutes, Ghana; Environmental Protection Authority, Ghana; Korle-Bu Teaching Hospital, Ghana; University Hospital, Kwame Nkrumah University of Science and Technology, Ghana; Department of Pharmacy Practice, Kwame Nkrumah University of Science and Technology, Ghana. We deeply appreciate all the staff at the Health Information Unit, ICT department, and bacteriology laboratory unit of the Ho Teaching Hospital for their efforts in curating data for this study. We gratefully acknowledge the contributions of all participating institutions and partners.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, R.S., E.B.-Y.,P.T., H.O. and A.M.V.K.; methodology, R.S. and E.B.-Y.; software, P.T.; validation, R.S., E.B.-Y. and P.K.K.; formal analysis, R.S., E.B.-Y., P.K.K., P.T. and A.M.V.K.; data curation, R.S., E.B.-Y., C.C.D., E.A. and B.S.; writing&#8212;original draft preparation, R.S., E.B.-Y. and A.M.V.K.; writing&#8212;review and editing, R.S., E.B.-Y., P.K.K., E.A., B.S., P.T., H.O., A.M.V.K. and C.C.D. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Ethics approval was granted by the Research Ethics Committee of the Ho Teaching Hospital, Ho, Ghana (protocol number HTH-REC (24) FC_2024) and the Ethics Advisory Group (EAG) of the International Union Against Tuberculosis and Lung Disease (EAG number 26/24). Permission was obtained from the &#8220;Research, Policy, Planning, Monitoring and Evaluation Directorate&#8221; of HTH to access the patient data.</p></notes><notes><title>Informed Consent Statement</title><p>Since this was a retrospective study using programme data and did not directly recruit human participants, the need for informed consent was waived by the ethics committees.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Requests to access these data should be sent to the corresponding author.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</p></notes><ref-list><title>References</title><ref id="B1-tropicalmed-10-00270"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seni</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mwakyoma</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Mashuda</surname><given-names>F.</given-names></name><name name-style="western"><surname>Marando</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>M.</given-names></name><name name-style="western"><surname>DeVinney</surname><given-names>R.</given-names></name><name name-style="western"><surname>Pitout</surname><given-names>J.D.D.</given-names></name><name name-style="western"><surname>Mshana</surname><given-names>S.E.</given-names></name></person-group><article-title>Deciphering risk factors for blood stream infections, bacteria species and antimicrobial resistance profiles among children under five years of age in North-Western Tanzania: A multicentre study in a cascade of referral health care system</article-title><source>BMC Pediatr.</source><year>2019</year><volume>19</volume><elocation-id>32</elocation-id><pub-id pub-id-type="doi">10.1186/s12887-019-1411-0</pub-id><pub-id pub-id-type="pmid">30684964</pub-id><pub-id pub-id-type="pmcid">PMC6347777</pub-id></element-citation></ref><ref id="B2-tropicalmed-10-00270"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martinez</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Wolk</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Hayden</surname><given-names>R.T.</given-names></name><name name-style="western"><surname>Carroll</surname><given-names>K.C.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y.-W.</given-names></name></person-group><article-title>Bloodstream Infections</article-title><source>Microbiol. Spectr.</source><year>2016</year><volume>4</volume><fpage>653</fpage><lpage>689</lpage><pub-id pub-id-type="doi">10.1128/microbiolspec.DMIH2-0031-2016</pub-id><pub-id pub-id-type="pmid">27726765</pub-id></element-citation></ref><ref id="B3-tropicalmed-10-00270"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cassini</surname><given-names>A.</given-names></name><name name-style="western"><surname>H&#246;gberg</surname><given-names>L.D.</given-names></name><name name-style="western"><surname>Plachouras</surname><given-names>D.</given-names></name><name name-style="western"><surname>Quattrocchi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hoxha</surname><given-names>A.</given-names></name><name name-style="western"><surname>Simonsen</surname><given-names>G.S.</given-names></name><name name-style="western"><surname>Colomb-Cotinat</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kretzschmar</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Devleesschauwer</surname><given-names>B.</given-names></name><name name-style="western"><surname>Cecchini</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis</article-title><source>Lancet Infect. Dis.</source><year>2019</year><volume>19</volume><fpage>56</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(18)30605-4</pub-id><pub-id pub-id-type="pmid">30409683</pub-id><pub-id pub-id-type="pmcid">PMC6300481</pub-id></element-citation></ref><ref id="B4-tropicalmed-10-00270"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Kraker</surname><given-names>M.E.A.</given-names></name></person-group><article-title>Understanding the impact of antimicrobial resistance on outcomes of bloodstream infections in low- and middle-income countries</article-title><source>PLoS Med.</source><year>2023</year><volume>20</volume><elocation-id>e1004262</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1004262</pub-id><pub-id pub-id-type="pmid">37436835</pub-id><pub-id pub-id-type="pmcid">PMC10337827</pub-id></element-citation></ref><ref id="B5-tropicalmed-10-00270"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deku</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Dakorah</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Lokpo</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Orish</surname><given-names>V.N.</given-names></name><name name-style="western"><surname>Ussher</surname><given-names>F.A.</given-names></name><name name-style="western"><surname>Kpene</surname><given-names>G.E.</given-names></name><name name-style="western"><surname>Eshun</surname><given-names>V.A.</given-names></name><name name-style="western"><surname>Agyei</surname><given-names>E.</given-names></name><name name-style="western"><surname>Attivor</surname><given-names>W.</given-names></name><name name-style="western"><surname>Osei-Yeboah</surname><given-names>J.</given-names></name></person-group><article-title>The Epidemiology of Bloodstream Infections and Antimicrobial Susceptibility Patterns: A Nine-Year Retrospective Study at St. Dominic Hospital, Akwatia, Ghana</article-title><source>J. Trop. Med.</source><year>2019</year><volume>2019</volume><fpage>6750864</fpage><pub-id pub-id-type="doi">10.1155/2019/6750864</pub-id><pub-id pub-id-type="pmid">31641359</pub-id><pub-id pub-id-type="pmcid">PMC6770298</pub-id></element-citation></ref><ref id="B6-tropicalmed-10-00270"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Obeng-Nkrumah</surname><given-names>N.</given-names></name><name name-style="western"><surname>Labi</surname><given-names>A.-K.</given-names></name><name name-style="western"><surname>Addison</surname><given-names>N.O.</given-names></name><name name-style="western"><surname>Labi</surname><given-names>J.E.M.</given-names></name><name name-style="western"><surname>Awuah-Mensah</surname><given-names>G.</given-names></name></person-group><article-title>Trends in paediatric and adult bloodstream infections at a Ghanaian referral hospital: A retrospective study</article-title><source>Ann. Clin. Microbiol. Antimicrob.</source><year>2016</year><volume>15</volume><elocation-id>49</elocation-id><pub-id pub-id-type="doi">10.1186/s12941-016-0163-z</pub-id><pub-id pub-id-type="pmid">27539221</pub-id><pub-id pub-id-type="pmcid">PMC4991019</pub-id></element-citation></ref><ref id="B7-tropicalmed-10-00270"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zasowski</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Bassetti</surname><given-names>M.</given-names></name><name name-style="western"><surname>Blasi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Goossens</surname><given-names>H.</given-names></name><name name-style="western"><surname>Rello</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sotgiu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Tavoschi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Arber</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>McCool</surname><given-names>R.</given-names></name><name name-style="western"><surname>Patterson</surname><given-names>J.V.</given-names></name><etal/></person-group><article-title>A Systematic Review of the Effect of Delayed Appropriate Antibiotic Treatment on the Outcomes of Patients with Severe Bacterial Infections</article-title><source>Chest</source><year>2020</year><volume>158</volume><fpage>929</fpage><lpage>938</lpage><pub-id pub-id-type="doi">10.1016/j.chest.2020.03.087</pub-id><pub-id pub-id-type="pmid">32446623</pub-id></element-citation></ref><ref id="B8-tropicalmed-10-00270"><label>8.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>Implementing the Global Action Plan on Antimicrobial Resistance: First Quadripartite Biennial Report</source><publisher-name>World Health Organization, Food and Agriculture Organization of the United Nations, United Nations Environment Programme and World Organization for Animal Health</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><year>2023</year><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by-nc-sa/3.0/igo/" ext-link-type="uri">https://creativecommons.org/licenses/by-nc-sa/3.0/igo/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-08-01">(accessed on 1 August 2025)</date-in-citation></element-citation></ref><ref id="B9-tropicalmed-10-00270"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maki</surname><given-names>G.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>I.</given-names></name><name name-style="western"><surname>Paulin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kaljee</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kasambara</surname><given-names>W.</given-names></name><name name-style="western"><surname>Mlotha</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chuki</surname><given-names>P.</given-names></name><name name-style="western"><surname>Rupali</surname><given-names>P.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Bajracharya</surname><given-names>D.C.</given-names></name><etal/></person-group><article-title>Feasibility study of the world health organization health care facility-based antimicrobial stewardship toolkit for low- and Middle-Income countries</article-title><source>Antibiotics</source><year>2020</year><volume>9</volume><elocation-id>556</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics9090556</pub-id><pub-id pub-id-type="pmid">32872440</pub-id><pub-id pub-id-type="pmcid">PMC7558985</pub-id></element-citation></ref><ref id="B10-tropicalmed-10-00270"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krapp</surname><given-names>F.</given-names></name><name name-style="western"><surname>Rondon</surname><given-names>C.</given-names></name><name name-style="western"><surname>Amaro</surname><given-names>C.</given-names></name><name name-style="western"><surname>Barco-Yaip&#233;n</surname><given-names>E.</given-names></name><name name-style="western"><surname>Valera-Krumdieck</surname><given-names>M.</given-names></name><name name-style="western"><surname>V&#225;squez</surname><given-names>R.</given-names></name><name name-style="western"><surname>Briones</surname><given-names>A.</given-names></name><name name-style="western"><surname>Casapia</surname><given-names>M.</given-names></name><name name-style="western"><surname>Burgos</surname><given-names>A.</given-names></name><name name-style="western"><surname>L&#243;pez</surname><given-names>F.S.</given-names></name><etal/></person-group><article-title>Underutilization and Quality Gaps in Blood Culture Processing in Public Hospitals of Peru</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2022</year><volume>106</volume><fpage>432</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.21-0770</pub-id><pub-id pub-id-type="pmcid">PMC8832895</pub-id><pub-id pub-id-type="pmid">34872054</pub-id></element-citation></ref><ref id="B11-tropicalmed-10-00270"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Droz</surname><given-names>N.</given-names></name><name name-style="western"><surname>Hsia</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ellis</surname><given-names>S.</given-names></name><name name-style="western"><surname>Dramowski</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sharland</surname><given-names>M.</given-names></name><name name-style="western"><surname>Basmaci</surname><given-names>R.</given-names></name></person-group><article-title>Bacterial pathogens and resistance causing community acquired paediatric bloodstream infections in low- and middle-income countries: A systematic review and meta-analysis</article-title><source>Antimicrob. Resist. Infect. Control</source><year>2019</year><volume>8</volume><fpage>207</fpage><pub-id pub-id-type="doi">10.1186/s13756-019-0673-5</pub-id><pub-id pub-id-type="pmid">31893041</pub-id><pub-id pub-id-type="pmcid">PMC6937962</pub-id></element-citation></ref><ref id="B12-tropicalmed-10-00270"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pan</surname><given-names>H.-W.</given-names></name><name name-style="western"><surname>Li</surname><given-names>W.</given-names></name><name name-style="western"><surname>Li</surname><given-names>R.-G.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>E.-H.</given-names></name></person-group><article-title>Simple sample preparation method for direct microbial identification and susceptibility testing from positive blood cultures</article-title><source>Front. Microbiol.</source><year>2018</year><volume>9</volume><elocation-id>481</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2018.00481</pub-id><pub-id pub-id-type="pmid">29616003</pub-id><pub-id pub-id-type="pmcid">PMC5869256</pub-id></element-citation></ref><ref id="B13-tropicalmed-10-00270"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Opintan</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Newman</surname><given-names>M.J.</given-names></name></person-group><article-title>Prevalence of antimicrobial resistant pathogens from blood cultures: Results from a laboratory based nationwide surveillance in Ghana</article-title><source>Antimicrob. Resist. Infect. Control</source><year>2017</year><volume>6</volume><fpage>64</fpage><pub-id pub-id-type="doi">10.1186/s13756-017-0221-0</pub-id><pub-id pub-id-type="pmid">28630688</pub-id><pub-id pub-id-type="pmcid">PMC5470323</pub-id></element-citation></ref><ref id="B14-tropicalmed-10-00270"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Minton</surname><given-names>J.</given-names></name><name name-style="western"><surname>Clayton</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sandoe</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gann</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>Wilcox</surname><given-names>M.</given-names></name></person-group><article-title>Quality Improvement Report: Improving early management of bloodstream infection: A quality improvement project</article-title><source>BMJ Br. Med. J.</source><year>2008</year><volume>336</volume><fpage>440</fpage><pub-id pub-id-type="doi">10.1136/bmj.39454.634502.80</pub-id><pub-id pub-id-type="pmid">18292170</pub-id><pub-id pub-id-type="pmcid">PMC2249678</pub-id></element-citation></ref><ref id="B15-tropicalmed-10-00270"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Idelevich</surname><given-names>E.</given-names></name><name name-style="western"><surname>Seifert</surname><given-names>H.</given-names></name><name name-style="western"><surname>Sundqvist</surname><given-names>M.</given-names></name><name name-style="western"><surname>Scudeller</surname><given-names>L.</given-names></name><name name-style="western"><surname>Amit</surname><given-names>S.</given-names></name><name name-style="western"><surname>Balode</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bilozor</surname><given-names>A.</given-names></name><name name-style="western"><surname>Drevinek</surname><given-names>P.</given-names></name><name name-style="western"><surname>Tufan</surname><given-names>Z.K.</given-names></name><name name-style="western"><surname>Koraqi</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Microbiological diagnostics of bloodstream infections in Europe&#8212;An ESGBIES survey</article-title><source>Clin. Microbiol. Infect.</source><year>2019</year><volume>25</volume><fpage>1399</fpage><lpage>1407</lpage><pub-id pub-id-type="doi">10.1016/j.cmi.2019.03.024</pub-id><pub-id pub-id-type="pmid">30980927</pub-id></element-citation></ref><ref id="B16-tropicalmed-10-00270"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boakye-Yiadom</surname><given-names>E.</given-names></name><name name-style="western"><surname>Najjemba</surname><given-names>R.</given-names></name><name name-style="western"><surname>Thekkur</surname><given-names>P.</given-names></name><name name-style="western"><surname>Labi</surname><given-names>A.-K.</given-names></name><name name-style="western"><surname>Gil-Cuesta</surname><given-names>J.</given-names></name><name name-style="western"><surname>Asafo-Adjei</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mensah</surname><given-names>P.</given-names></name><name name-style="western"><surname>van Boetzelaer</surname><given-names>E.</given-names></name><name name-style="western"><surname>Jessani</surname><given-names>N.S.</given-names></name><name name-style="western"><surname>Orish</surname><given-names>V.N.</given-names></name></person-group><article-title>Use and Quality of Blood Cultures for the Diagnosis of Bloodstream Infections: A Cross-Sectional Study in the Ho Teaching Hospital, Ghana, 2019&#8211;2021</article-title><source>Int. J. Environ. Res. Public Health</source><year>2023</year><volume>20</volume><elocation-id>6631</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph20176631</pub-id><pub-id pub-id-type="pmid">37681771</pub-id><pub-id pub-id-type="pmcid">PMC10487590</pub-id></element-citation></ref><ref id="B17-tropicalmed-10-00270"><label>17.</label><element-citation publication-type="gov"><article-title>Ghana 2024 Statistical Year Overview Ghana Statistical Service</article-title><year>2024</year><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://statsghana.gov.gh/gssmain/fileUpload/pressrelease/Ghana%20Statistical%20Service%202024%20Releases%20-%20online.pdf" ext-link-type="uri">https://statsghana.gov.gh/gssmain/fileUpload/pressrelease/Ghana%20Statistical%20Service%202024%20Releases%20-%20online.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-07-22">(accessed on 22 July 2025)</date-in-citation></element-citation></ref><ref id="B18-tropicalmed-10-00270"><label>18.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Lewis</surname><given-names>J.S.</given-names></name></person-group><source>Performance Standards for Antimicrobial Susceptibility Testing</source><publisher-name>Clinical and Laboratory Standards Institute</publisher-name><publisher-loc>Malvern, PA, USA</publisher-loc><year>2024</year><size units="pages">382p</size></element-citation></ref><ref id="B19-tropicalmed-10-00270"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Halstead</surname><given-names>D.C.</given-names></name><name name-style="western"><surname>Sautter</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Snyder</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Crist</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Nachamkin</surname><given-names>I.</given-names></name></person-group><article-title>Reducing Blood Culture Contamination Rates: Experiences of Four Hospital Systems</article-title><source>Infect. Dis. Ther.</source><year>2020</year><volume>9</volume><fpage>389</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1007/s40121-020-00299-1</pub-id><pub-id pub-id-type="pmid">32350778</pub-id><pub-id pub-id-type="pmcid">PMC7237585</pub-id></element-citation></ref><ref id="B20-tropicalmed-10-00270"><label>20.</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Center for Disease Control and Prevention</collab></person-group><article-title>Blood Culture Contamination: An Overview for Infection Control and Antibiotic Stewardship Programs Working with the Clinical Laboratory</article-title><year>2022</year><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cap.org/laboratory-improvement/accreditation/" ext-link-type="uri">https://www.cap.org/laboratory-improvement/accreditation/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-07-23">(accessed on 23 July 2025)</date-in-citation></element-citation></ref><ref id="B21-tropicalmed-10-00270"><label>21.</label><element-citation publication-type="webpage"><person-group person-group-type="author"><name name-style="western"><surname>Fraser</surname><given-names>J.</given-names></name><name name-style="western"><surname>Skone-James</surname><given-names>R.</given-names></name><name name-style="western"><surname>Foster</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rosado</surname><given-names>H.</given-names></name><name name-style="western"><surname>Brandish</surname><given-names>C.</given-names></name><name name-style="western"><surname>Nabiryo</surname><given-names>M.</given-names></name></person-group><article-title>Commonwealth Partnerships for Antimicrobial Stewardship (CWPAMS) Impact Report</article-title><year>2024</year><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://commonwealthpharmacy.org/" ext-link-type="uri">https://commonwealthpharmacy.org/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-08-01">(accessed on 1 August 2025)</date-in-citation></element-citation></ref><ref id="B22-tropicalmed-10-00270"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McErlean</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kpokiri</surname><given-names>E.</given-names></name><name name-style="western"><surname>Panesar</surname><given-names>P.</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>E.E.</given-names></name><name name-style="western"><surname>Jato</surname><given-names>J.</given-names></name><name name-style="western"><surname>Orman</surname><given-names>E.</given-names></name><name name-style="western"><surname>Odoi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Hutton-Nyameaye</surname><given-names>A.</given-names></name><name name-style="western"><surname>Somuah</surname><given-names>S.O.</given-names></name><name name-style="western"><surname>Folitse</surname><given-names>I.</given-names></name><etal/></person-group><article-title>Evaluation of a Hub-and-Spoke Model to Enhance Healthcare Professionals&#8217; Practice of Antimicrobial Stewardship (AMS) Programmes in the Volta Region of Ghana</article-title><source>Antibiotics</source><year>2025</year><volume>14</volume><elocation-id>672</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics14070672</pub-id><pub-id pub-id-type="pmid">40723975</pub-id><pub-id pub-id-type="pmcid">PMC12291810</pub-id></element-citation></ref><ref id="B23-tropicalmed-10-00270"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ashiru-Oredope</surname><given-names>D.</given-names></name><name name-style="western"><surname>Nabiryo</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zengeni</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kamere</surname><given-names>N.</given-names></name><name name-style="western"><surname>Makotose</surname><given-names>A.</given-names></name><name name-style="western"><surname>Olaoye</surname><given-names>O.</given-names></name><name name-style="western"><surname>Townsend</surname><given-names>W.</given-names></name><name name-style="western"><surname>Waddingham</surname><given-names>B.</given-names></name><name name-style="western"><surname>Matuluko</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nambatya</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Tackling antimicrobial resistance: Developing and implementing antimicrobial stewardship interventions in four African commonwealth countries through a health partnership model</article-title><source>J. Public Health Afr.</source><year>2023</year><volume>14</volume><fpage>7</fpage><pub-id pub-id-type="doi">10.4081/jphia.2023.2335</pub-id><pub-id pub-id-type="pmcid">PMC10395364</pub-id><pub-id pub-id-type="pmid">37538939</pub-id></element-citation></ref><ref id="B24-tropicalmed-10-00270"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ombelet</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kpossou</surname><given-names>G.</given-names></name><name name-style="western"><surname>Kotchare</surname><given-names>C.</given-names></name><name name-style="western"><surname>Agbobli</surname><given-names>E.</given-names></name><name name-style="western"><surname>Sogbo</surname><given-names>F.</given-names></name><name name-style="western"><surname>Massou</surname><given-names>F.</given-names></name><name name-style="western"><surname>Lagrou</surname><given-names>K.</given-names></name><name name-style="western"><surname>Barb&#233;</surname><given-names>B.</given-names></name><name name-style="western"><surname>Affolabi</surname><given-names>D.</given-names></name><name name-style="western"><surname>Jacobs</surname><given-names>J.</given-names></name></person-group><article-title>Blood culture surveillance in a secondary care hospital in Benin: Epidemiology of bloodstream infection pathogens and antimicrobial resistance</article-title><source>BMC Infect. Dis.</source><year>2022</year><volume>22</volume><elocation-id>119</elocation-id><pub-id pub-id-type="doi">10.1186/s12879-022-07077-z</pub-id><pub-id pub-id-type="pmid">35114948</pub-id><pub-id pub-id-type="pmcid">PMC8812239</pub-id></element-citation></ref><ref id="B25-tropicalmed-10-00270"><label>25.</label><element-citation publication-type="webpage"><article-title>Standard Treatment Guidelines</article-title><year>2017</year><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.ghndp.org" ext-link-type="uri">www.ghndp.org</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-07-22">(accessed on 22 July 2025)</date-in-citation></element-citation></ref><ref id="B26-tropicalmed-10-00270"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahden</surname><given-names>P.</given-names></name><name name-style="western"><surname>Barrow</surname><given-names>E.</given-names></name><name name-style="western"><surname>Bah</surname><given-names>H.</given-names></name><name name-style="western"><surname>Bittaye</surname><given-names>S.O.</given-names></name><name name-style="western"><surname>Nygren</surname><given-names>D.</given-names></name><name name-style="western"><surname>Badjan</surname><given-names>A.</given-names></name></person-group><article-title>Bloodstream infections at a tertiary hospital in the Gambia&#8212;A one-year retrospective study</article-title><source>BMC Infect. Dis.</source><year>2025</year><volume>25</volume><elocation-id>170</elocation-id><pub-id pub-id-type="doi">10.1186/s12879-025-10533-1</pub-id><pub-id pub-id-type="pmid">39910483</pub-id><pub-id pub-id-type="pmcid">PMC11800432</pub-id></element-citation></ref><ref id="B27-tropicalmed-10-00270"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsu</surname><given-names>P.-H.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>C.-H.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.-S.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.-S.</given-names></name></person-group><article-title>Association between blood culture turnaround time and clinical prognosis in emergency department patients with community acquired bloodstream infection: A retrospective study based on electronic medical records</article-title><source>Heliyon</source><year>2024</year><volume>10</volume><fpage>e27957</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2024.e27957</pub-id><pub-id pub-id-type="pmid">38532997</pub-id><pub-id pub-id-type="pmcid">PMC10963333</pub-id></element-citation></ref><ref id="B28-tropicalmed-10-00270"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dempsey</surname><given-names>C.</given-names></name><name name-style="western"><surname>Skoglund</surname><given-names>E.</given-names></name><name name-style="western"><surname>Muldrew</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Garey</surname><given-names>K.W.</given-names></name></person-group><article-title>Economic health care costs of blood culture contamination: A systematic review</article-title><source>Am. J. Infect. Control</source><year>2019</year><volume>47</volume><fpage>963</fpage><lpage>967</lpage><pub-id pub-id-type="doi">10.1016/j.ajic.2018.12.020</pub-id><pub-id pub-id-type="pmid">30795840</pub-id></element-citation></ref><ref id="B29-tropicalmed-10-00270"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dr&#228;ger</surname><given-names>S.</given-names></name><name name-style="western"><surname>Giehl</surname><given-names>C.</given-names></name><name name-style="western"><surname>S&#248;gaard</surname><given-names>K.K.</given-names></name><name name-style="western"><surname>Egli</surname><given-names>A.</given-names></name><name name-style="western"><surname>de Roche</surname><given-names>M.</given-names></name><name name-style="western"><surname>Huber</surname><given-names>L.C.</given-names></name><name name-style="western"><surname>Osthoff</surname><given-names>M.</given-names></name></person-group><article-title>Do we need blood culture stewardship programs? A quality control study and survey to assess the appropriateness of blood culture collection and the knowledge and attitudes among physicians in Swiss hospitals</article-title><source>Eur. J. Intern. Med.</source><year>2022</year><volume>103</volume><fpage>50</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.ejim.2022.04.028</pub-id><pub-id pub-id-type="pmid">35715280</pub-id></element-citation></ref><ref id="B30-tropicalmed-10-00270"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donkor</surname><given-names>E.S.</given-names></name><name name-style="western"><surname>Muhsen</surname><given-names>K.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>S.A.M.</given-names></name><name name-style="western"><surname>Kotey</surname><given-names>F.C.N.</given-names></name><name name-style="western"><surname>Dayie</surname><given-names>N.T.K.D.</given-names></name><name name-style="western"><surname>Tetteh-Quarcoo</surname><given-names>P.B.</given-names></name><name name-style="western"><surname>Tette</surname><given-names>E.M.A.</given-names></name><name name-style="western"><surname>Osei</surname><given-names>M.-M.</given-names></name><name name-style="western"><surname>Egyir</surname><given-names>B.</given-names></name><name name-style="western"><surname>Nii-Trebi</surname><given-names>N.I.</given-names></name><etal/></person-group><article-title>Multicenter Surveillance of Antimicrobial Resistance among Gram-Negative Bacteria Isolated from Bloodstream Infections in Ghana</article-title><source>Antibiotics</source><year>2023</year><volume>12</volume><elocation-id>255</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics12020255</pub-id><pub-id pub-id-type="pmid">36830166</pub-id><pub-id pub-id-type="pmcid">PMC9951917</pub-id></element-citation></ref><ref id="B31-tropicalmed-10-00270"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Labi</surname><given-names>A.-K.</given-names></name><name name-style="western"><surname>Obeng-Nkrumah</surname><given-names>N.</given-names></name><name name-style="western"><surname>Bjerrum</surname><given-names>S.</given-names></name><name name-style="western"><surname>Enweronu-Laryea</surname><given-names>C.</given-names></name><name name-style="western"><surname>Newman</surname><given-names>M.J.</given-names></name></person-group><article-title>Neonatal bloodstream infections in a Ghanaian Tertiary Hospital: Are the current antibiotic recommendations adequate?</article-title><source>BMC Infect. Dis.</source><year>2016</year><volume>16</volume><elocation-id>598</elocation-id><pub-id pub-id-type="doi">10.1186/s12879-016-1913-4</pub-id><pub-id pub-id-type="pmid">27776490</pub-id><pub-id pub-id-type="pmcid">PMC5078915</pub-id></element-citation></ref><ref id="B32-tropicalmed-10-00270"><label>32.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>WHO Bacterial Priority Pathogens List, 2024-Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance</source><publisher-name>World Health Organization</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><year>2024</year><fpage>1</fpage><lpage>72</lpage><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://iris.who.int/bitstream/handle/10665/376776/9789240093461-eng.pdf" ext-link-type="uri">https://iris.who.int/bitstream/handle/10665/376776/9789240093461-eng.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-07-23">(accessed on 23 July 2025)</date-in-citation></element-citation></ref><ref id="B33-tropicalmed-10-00270"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seboxa</surname><given-names>T.</given-names></name><name name-style="western"><surname>Amogne</surname><given-names>W.</given-names></name><name name-style="western"><surname>Abebe</surname><given-names>W.</given-names></name><name name-style="western"><surname>Tsegaye</surname><given-names>T.</given-names></name><name name-style="western"><surname>Azazh</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hailu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Fufa</surname><given-names>K.</given-names></name><name name-style="western"><surname>Grude</surname><given-names>N.</given-names></name><name name-style="western"><surname>Henriksen</surname><given-names>T.-H.</given-names></name><name name-style="western"><surname>Quach</surname><given-names>C.</given-names></name></person-group><article-title>High mortality from blood stream infection in Addis Ababa, Ethiopia, is due to antimicrobial resistance</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0144944</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0144944</pub-id><pub-id pub-id-type="pmid">26670718</pub-id><pub-id pub-id-type="pmcid">PMC4682922</pub-id></element-citation></ref><ref id="B34-tropicalmed-10-00270"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barman</surname><given-names>P.</given-names></name><name name-style="western"><surname>Chopra</surname><given-names>S.</given-names></name><name name-style="western"><surname>Thukral</surname><given-names>T.</given-names></name></person-group><article-title>Direct testing by VITEK<sup>&#174;</sup> 2: A dependable method to reduce turnaround time in Gram-negative bloodstream infections</article-title><source>J. Lab. Physicians</source><year>2018</year><volume>10</volume><fpage>260</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.4103/JLP.JLP_11_18</pub-id><pub-id pub-id-type="pmid">30078959</pub-id><pub-id pub-id-type="pmcid">PMC6052814</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="tropicalmed-10-00270-f001" orientation="portrait"><label>Figure 1</label><caption><p>Utilisation and quality of blood cultures among inpatients with clinically suspected bloodstream infections at the Ho Teaching Hospital, Ghana, 2024.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="tropicalmed-10-00270-g001.jpg"/></fig><table-wrap position="float" id="tropicalmed-10-00270-t001" orientation="portrait"><object-id pub-id-type="pii">tropicalmed-10-00270-t001_Table 1</object-id><label>Table 1</label><caption><p>Demographic and clinical characteristics associated with blood culture request among inpatients with suspected bloodstream infections at the Ho Teaching Hospital, Ghana, 2024.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Total N(%) ^</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">CDST Request N(%) *</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PR (95% CI)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">aPR <sup>&#946;</sup> (95% CI)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1080</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(100)</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">432</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(40.0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Age</bold>
</td><td align="right" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="right" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Neonate (0&#8211;28 days)</td><td align="right" valign="middle" rowspan="1" colspan="1">249</td><td align="left" valign="middle" rowspan="1" colspan="1">(23.1)</td><td align="right" valign="middle" rowspan="1" colspan="1">155</td><td align="left" valign="middle" rowspan="1" colspan="1">(62.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.5 (1.9&#8211;3.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">29 days to &lt;1 year</td><td align="right" valign="middle" rowspan="1" colspan="1">39</td><td align="left" valign="middle" rowspan="1" colspan="1">(3.6)</td><td align="right" valign="middle" rowspan="1" colspan="1">24</td><td align="left" valign="middle" rowspan="1" colspan="1">(61.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.5 (1.8&#8211;3.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1&#8211;4 years</td><td align="right" valign="middle" rowspan="1" colspan="1">77</td><td align="left" valign="middle" rowspan="1" colspan="1">(7.1)</td><td align="right" valign="middle" rowspan="1" colspan="1">48</td><td align="left" valign="middle" rowspan="1" colspan="1">(62.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.5 (1.9&#8211;3.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">5&#8211;11 years</td><td align="right" valign="middle" rowspan="1" colspan="1">54</td><td align="left" valign="middle" rowspan="1" colspan="1">(5.0)</td><td align="right" valign="middle" rowspan="1" colspan="1">37</td><td align="left" valign="middle" rowspan="1" colspan="1">(68.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.8 (2.0&#8211;3.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">12&#8211;24 years</td><td align="right" valign="middle" rowspan="1" colspan="1">114</td><td align="left" valign="middle" rowspan="1" colspan="1">(10.6)</td><td align="right" valign="middle" rowspan="1" colspan="1">29</td><td align="left" valign="middle" rowspan="1" colspan="1">(25.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.0 (0.7&#8211;1.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">25&#8211;44 years</td><td align="right" valign="middle" rowspan="1" colspan="1">172</td><td align="left" valign="middle" rowspan="1" colspan="1">(15.9)</td><td align="right" valign="middle" rowspan="1" colspan="1">37</td><td align="left" valign="middle" rowspan="1" colspan="1">(21.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.9 (0.6&#8211;1.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">45&#8211;64 years</td><td align="right" valign="middle" rowspan="1" colspan="1">173</td><td align="left" valign="middle" rowspan="1" colspan="1">(16.0)</td><td align="right" valign="middle" rowspan="1" colspan="1">52</td><td align="left" valign="middle" rowspan="1" colspan="1">(30.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.2 (0.9&#8211;1.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8805;65 years</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">202</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(18.7)</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(24.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Sex</bold>
</td><td align="right" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="right" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Male</td><td align="right" valign="middle" rowspan="1" colspan="1">524</td><td align="left" valign="middle" rowspan="1" colspan="1">(48.5)</td><td align="right" valign="middle" rowspan="1" colspan="1">207</td><td align="left" valign="middle" rowspan="1" colspan="1">(39.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Female</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">556</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(51.5)</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">225</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(40.5)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.0 (0.9&#8211;1.2)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.0 (0.9&#8211;1.1)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.843</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Condition ***</bold>
</td><td align="right" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="right" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Neonatal sepsis</td><td align="right" valign="middle" rowspan="1" colspan="1">242</td><td align="left" valign="middle" rowspan="1" colspan="1">(22.4)</td><td align="right" valign="middle" rowspan="1" colspan="1">147</td><td align="left" valign="middle" rowspan="1" colspan="1">(60.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.4 (2.0&#8211;2.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.4 (1.1&#8211;1.7)</td><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>0.003</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Pneumonia</td><td align="right" valign="middle" rowspan="1" colspan="1">368</td><td align="left" valign="middle" rowspan="1" colspan="1">(34.1)</td><td align="right" valign="middle" rowspan="1" colspan="1">93</td><td align="left" valign="middle" rowspan="1" colspan="1">(25.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Other sepsis <sup>1</sup></td><td align="right" valign="middle" rowspan="1" colspan="1">227</td><td align="left" valign="middle" rowspan="1" colspan="1">(21.0)</td><td align="right" valign="middle" rowspan="1" colspan="1">119</td><td align="left" valign="middle" rowspan="1" colspan="1">(52.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.1 (1.7&#8211;2.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.0 (1.6&#8211;2.4)</td><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>&lt;0.001</bold>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Other conditions <sup>2</sup></td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">243</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(22.5)</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">73</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(30.0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.2 (0.9&#8211;1.5)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.4 (1.1&#8211;1.7)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>0.011</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Department</bold>
</td><td align="right" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="right" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Intensive Care Unit</td><td align="right" valign="middle" rowspan="1" colspan="1">30</td><td align="left" valign="middle" rowspan="1" colspan="1">(2.8)</td><td align="right" valign="middle" rowspan="1" colspan="1">16</td><td align="left" valign="middle" rowspan="1" colspan="1">(53.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.5 (2.1&#8211;5.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.5 (2.2&#8211;5.7)</td><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>&lt;0.001</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Accident and Emergency</td><td align="right" valign="middle" rowspan="1" colspan="1">168</td><td align="left" valign="middle" rowspan="1" colspan="1">(15.6)</td><td align="right" valign="middle" rowspan="1" colspan="1">41</td><td align="left" valign="middle" rowspan="1" colspan="1">(24.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.6 (1.0&#8211;2.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.8 (1.1&#8211;2.8)</td><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>0.013</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Child Health </td><td align="right" valign="middle" rowspan="1" colspan="1">422</td><td align="left" valign="middle" rowspan="1" colspan="1">(39.1)</td><td align="right" valign="middle" rowspan="1" colspan="1">264</td><td align="left" valign="middle" rowspan="1" colspan="1">(62.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.1 (2.8&#8211;6.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.2 (2.9&#8211;6.2)</td><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>&lt;0.001</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Internal Medicine</td><td align="right" valign="middle" rowspan="1" colspan="1">261</td><td align="left" valign="middle" rowspan="1" colspan="1">(24.2)</td><td align="right" valign="middle" rowspan="1" colspan="1">81</td><td align="left" valign="middle" rowspan="1" colspan="1">(31.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.1 (1.4&#8211;3.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.4 (1.6&#8211;3.7)</td><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>&lt;0.001</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Obstetrics and Gynaecology</td><td align="right" valign="middle" rowspan="1" colspan="1">47</td><td align="left" valign="middle" rowspan="1" colspan="1">(4.4)</td><td align="right" valign="middle" rowspan="1" colspan="1">7</td><td align="left" valign="middle" rowspan="1" colspan="1">(14.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.0 (0.5&#8211;2.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.9 (0.4&#8211;2.0)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.867</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Surgery</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">152</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(14.1)</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(15.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p>N = Total number of inpatients with suspected blood stream infections. ^ Column percentage. * Row percentage with category sub-total as the denominator. <sup>&#946;</sup> Adjusted analysis using binomial regression; age variable was removed from the adjusted model as it was found to be collinear with other variables with a variance inflation factor &gt; 10. Statistically significant associations are shown in bold. CDST = culture and drug susceptibility testing. PR = prevalence ratio. *** Only one diagnosis retrieved per patient. <sup>1</sup> Other sepsis = septic shock, severe sepsis, sepsis, septicaemia, puerperal sepsis, septic abortion, or sepsis following abortion. <sup>2</sup> Other conditions = endocarditis, pyelonephritis, typhoid fever, typhoid perforation, osteomyelitis, septic arthritis, intra-abdominal or pelvic abscesses, bacterial peritonitis, cholecystitis, spontaneous bacterial peritonitis, peritonitis, fever/pyrexia of unknown origin, Ludwig&#8217;s angina, and Fournier&#8217;s gangrene.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tropicalmed-10-00270-t002" orientation="portrait"><object-id pub-id-type="pii">tropicalmed-10-00270-t002_Table 2</object-id><label>Table 2</label><caption><p>Blood culture and drug susceptibility test processing time (in days) for inpatients with suspected blood stream infections in the Ho Teaching Hospital, Ghana during 2024.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Duration Between</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">n *</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Median Days</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">(IQR)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Admission and receipt of blood sample at laboratory for CDST</td><td align="center" valign="middle" rowspan="1" colspan="1">394</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">(0&#8211;2)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Receipt of blood sample at laboratory and issuance of CDST report <sup>#</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">390</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">(5&#8211;6)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Admission to issuance of final CDST report</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">373</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(6&#8211;8)</td></tr></tbody></table><table-wrap-foot><fn><p>* n, total number of observations with valid date for calculation of duration at each of the stages. CDST: Culture and drug susceptibility testing. IQR: Interquartile range. <sup>#</sup> Laboratory turnaround time (TAT).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tropicalmed-10-00270-t003" orientation="portrait"><object-id pub-id-type="pii">tropicalmed-10-00270-t003_Table 3</object-id><label>Table 3</label><caption><p>WHO priority pathogens isolated from blood cultures of inpatients with suspected blood stream infections at Ho Teaching Hospital, Ghana, 2024.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Organism</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">WHO Priority Category</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Isolates</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number Tested</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number Resistant</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Macrolide-resistant <italic toggle="yes">Streptococcus pyogenes</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">Medium</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MRSA (methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic>)</td><td align="center" valign="middle" rowspan="1" colspan="1">High</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Carbapenem-resistant <italic toggle="yes">Pseudomonas aeruginosa</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">High</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Carbapenem-resistant <italic toggle="yes">Acinetobacter baumanii</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">Critical</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Carbapenem-resistant Enterobacterales</td><td align="center" valign="middle" rowspan="1" colspan="1">Critical</td><td align="center" valign="middle" rowspan="1" colspan="1">19</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Ceftriaxone-resistant Enterobacterales</td><td align="center" valign="middle" rowspan="1" colspan="1">Critical</td><td align="center" valign="middle" rowspan="1" colspan="1">19</td><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ceftazidime-resistant Enterobacterales</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Critical</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td></tr></tbody></table></table-wrap><table-wrap position="float" id="tropicalmed-10-00270-t004" orientation="portrait"><object-id pub-id-type="pii">tropicalmed-10-00270-t004_Table 4</object-id><label>Table 4</label><caption><p>Factors associated with unfavourable hospital exit outcomes among inpatients with suspected bloodstream infections in the Ho Teaching Hospital, Ghana, 2024.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total N</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Unfavourable Outcome n(%) *</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">RR (95% CI)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">aRR <sup>&#946;</sup> (95% CI)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Total</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1080</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">243</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(22.5)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Age</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="right" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Neonate (0&#8211;28 days)</td><td align="left" valign="middle" rowspan="1" colspan="1">249</td><td align="right" valign="middle" rowspan="1" colspan="1">24</td><td align="left" valign="middle" rowspan="1" colspan="1">(9.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">29 days to &lt;1 year</td><td align="left" valign="middle" rowspan="1" colspan="1">39</td><td align="right" valign="middle" rowspan="1" colspan="1">2</td><td align="left" valign="middle" rowspan="1" colspan="1">(5.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.5 (0.1&#8211;2.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1&#8211;4 years</td><td align="left" valign="middle" rowspan="1" colspan="1">77</td><td align="right" valign="middle" rowspan="1" colspan="1">2</td><td align="left" valign="middle" rowspan="1" colspan="1">(2.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.3 (0.1&#8211;1.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">5&#8211;11 years</td><td align="left" valign="middle" rowspan="1" colspan="1">54</td><td align="right" valign="middle" rowspan="1" colspan="1">2</td><td align="left" valign="middle" rowspan="1" colspan="1">(3.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.4 (0.1&#8211;1.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">12&#8211;24 years</td><td align="left" valign="middle" rowspan="1" colspan="1">114</td><td align="right" valign="middle" rowspan="1" colspan="1">22</td><td align="left" valign="middle" rowspan="1" colspan="1">(19.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.0 (1.2&#8211;3.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">25&#8211;44 years</td><td align="left" valign="middle" rowspan="1" colspan="1">172</td><td align="right" valign="middle" rowspan="1" colspan="1">42</td><td align="left" valign="middle" rowspan="1" colspan="1">(24.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.5 (1.6&#8211;4.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">45&#8211;64 years</td><td align="left" valign="middle" rowspan="1" colspan="1">173</td><td align="right" valign="middle" rowspan="1" colspan="1">68</td><td align="left" valign="middle" rowspan="1" colspan="1">(39.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.1 (2.7&#8211;6.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&gt;=65 years</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">202</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">81</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(40.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.1 (2.7&#8211;6.3)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Sex</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="right" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Male</td><td align="left" valign="middle" rowspan="1" colspan="1">524</td><td align="right" valign="middle" rowspan="1" colspan="1">114</td><td align="left" valign="middle" rowspan="1" colspan="1">(21.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Female</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">556</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">129</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(23.2)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.1 (0.9&#8211;1.3)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.0 (0.8&#8211;1.2)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.700</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Condition ***</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="right" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Neonatal sepsis</td><td align="left" valign="middle" rowspan="1" colspan="1">242</td><td align="right" valign="middle" rowspan="1" colspan="1">18</td><td align="left" valign="middle" rowspan="1" colspan="1">(7.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Pneumonia</td><td align="left" valign="middle" rowspan="1" colspan="1">368</td><td align="right" valign="middle" rowspan="1" colspan="1">94</td><td align="left" valign="middle" rowspan="1" colspan="1">(25.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.4 (2.1&#8211;5.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.7 (0.3&#8211;1.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.427</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Other sepsis <sup>1</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">227</td><td align="right" valign="middle" rowspan="1" colspan="1">107</td><td align="left" valign="middle" rowspan="1" colspan="1">(47.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.3 (4.0&#8211;10.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.3 (0.6&#8211;2.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.496</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Other conditions <sup>2</sup></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">243</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(9.9)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.3 (0.7&#8211;2.4)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4 (0.2&#8211;0.9)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>0.024</bold>
</td></tr><tr><td colspan="2" align="left" valign="middle" rowspan="1">
<bold>Department **</bold>
</td><td align="right" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Intensive Care Unit</td><td align="left" valign="middle" rowspan="1" colspan="1">30</td><td align="right" valign="middle" rowspan="1" colspan="1">29</td><td align="left" valign="middle" rowspan="1" colspan="1">(96.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">15.1 (10.4&#8211;21.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">14.3 (7.5&#8211;27.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&lt;0.001</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Accident and Emergency</td><td align="left" valign="middle" rowspan="1" colspan="1">168</td><td align="right" valign="middle" rowspan="1" colspan="1">72</td><td align="left" valign="middle" rowspan="1" colspan="1">(42.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.7 (4.5&#8211;10.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.1 (3.7&#8211;13.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&lt;0.001</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Child Health</td><td align="left" valign="middle" rowspan="1" colspan="1">422</td><td align="right" valign="middle" rowspan="1" colspan="1">27</td><td align="left" valign="middle" rowspan="1" colspan="1">(6.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Internal Medicine</td><td align="left" valign="middle" rowspan="1" colspan="1">261</td><td align="right" valign="middle" rowspan="1" colspan="1">83</td><td align="left" valign="middle" rowspan="1" colspan="1">(31.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.0 (3.3&#8211;7.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.4 (2.8&#8211;10.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&lt;0.001</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Obstetrics and Gynaecology</td><td align="left" valign="middle" rowspan="1" colspan="1">47</td><td align="right" valign="middle" rowspan="1" colspan="1">9</td><td align="left" valign="middle" rowspan="1" colspan="1">(19.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.0 (1.5&#8211;6.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.8 (1.2&#8211;6.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.019</bold>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Surgery</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">152</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(15.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.4 (1.4&#8211;4.0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.1 (1.5&#8211;6.4)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>0.002</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>Culture Status</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="right" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">No culture/no results</td><td align="left" valign="middle" rowspan="1" colspan="1">660</td><td align="right" valign="middle" rowspan="1" colspan="1">148</td><td align="left" valign="middle" rowspan="1" colspan="1">(22.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.6 (0.7&#8211;3.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.7 (1.0&#8211;3.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.071</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">No bacterial growth</td><td align="left" valign="middle" rowspan="1" colspan="1">319</td><td align="right" valign="middle" rowspan="1" colspan="1">74</td><td align="left" valign="middle" rowspan="1" colspan="1">(23.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.6 (0.8&#8211;3.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.0 (1.1&#8211;3.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.024</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Contaminant</td><td align="left" valign="middle" rowspan="1" colspan="1">59</td><td align="right" valign="middle" rowspan="1" colspan="1">15</td><td align="left" valign="middle" rowspan="1" colspan="1">(25.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.8 (0.8&#8211;4.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.1 (1.1&#8211;4.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.037</bold>
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">True bacterial pathogen</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">42</td><td align="right" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(14.3)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p>* Row percentage with total as the denominator. <sup>&#946;</sup> Adjusted analysis using Poisson regression; age variable was removed from the adjusted model as it was found to be collinear with other variables with a variance inflation factor &gt; 10. Statistically significant associations are shown in bold. RR = risk ratio. ** Clinical department of ward first admitted. *** Only one diagnosis retrieved per patient. <sup>1</sup> Other sepsis = septic shock, severe sepsis, sepsis, septicaemia, puerperal sepsis, septic abortion, or sepsis following abortion. <sup>2</sup> Other = endocarditis, pyelonephritis, typhoid fever, typhoid perforation, osteomyelitis, septic arthritis, intra-abdominal or pelvic abscesses, bacterial peritonitis, cholecystitis, spontaneous bacterial peritonitis, peritonitis, fever/pyrexia of unknown origin, Ludwig&#8217;s angina, and Fournier&#8217;s gangrene.</p></fn></table-wrap-foot></table-wrap></floats-group></article></pmc-articleset>